STOCK TITAN

LifeMD, Inc. - LFMD STOCK NEWS

Welcome to our dedicated page for LifeMD news (Ticker: LFMD), a resource for investors and traders seeking the latest updates and insights on LifeMD stock.

LifeMD, Inc. (Nasdaq: LFMD) is a leading provider of virtual primary care, offering a comprehensive and integrated telehealth solution. The company's platform connects physicians, medical providers, pharmacists, and patients through a HIPAA-compliant system, ensuring secure AES-encrypted interactions. LifeMD provides a range of services including primary care, laboratory and pharmacy services, and specialized treatment for over 200 conditions such as men’s and women’s health, weight management, allergy & asthma, and dermatology.

LifeMD operates through two segments: Telehealth and WorkSimpli, with the majority of its revenue generated from the Telehealth segment. The company’s platform integrates electronic medical records (EMR), proprietary algorithms for case-load balancing and scheduling, customer relationship management (CRM), remote and in-home lab testing, digital prescription capabilities, and cloud pharmacy fulfillment. Additionally, LifeMD offers diagnostic telehealth equipment and sells nutritional supplements and over-the-counter products.

In 2023, LifeMD achieved significant business milestones, including the launch of a GLP-1 weight management program, which rapidly scaled to over 22,000 subscribers. The company also entered a strategic alliance with Medifast, receiving a $10 million collaboration fee and a $10 million equity investment. LifeMD continues to grow its RexMD brand, focusing on expanding telehealth products and services to increase patient lifetime value.

As of the end of 2023, LifeMD reported robust financial health with cash exceeding $30 million and a strong balance sheet. The company projects a revenue growth rate above 30% for 2024, alongside improvements in adjusted EBITDA and GAAP earnings. LifeMD remains optimistic about its strategic initiatives, including the expansion of private insurance-based programs and new offerings under its partnership with Medifast.

LifeMD is dedicated to making high-quality and affordable healthcare accessible to all, leveraging its vertically-integrated, proprietary digital care platform and a 50-state affiliated medical group. Its services are available 24/7/365, ensuring that patients can manage common medical conditions conveniently and cost-effectively.

Rhea-AI Summary
LifeMD, Inc. (LFMD) will announce financial results for Q4 and full year 2023 on March 11, 2024. The conference call will be held at 4:30 p.m. Eastern time. Investors can dial in to listen to the call or access the webcast.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
5.71%
Tags
conferences earnings
-
Rhea-AI Summary
LifeMD, Inc. (LFMD) announced participation in multiple investor conferences and a webinar to discuss GLP-1s. CEO Justin Schreiber will be presenting at various events to engage with investors and analysts.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
4.95%
Tags
conferences
-
Rhea-AI Summary
LifeMD, Inc. (LFMD) will participate in the 11th Annual BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference on February 13-14, 2024, at the Cliff Lodge in Snowbird, Utah. The company will hold one-on-one meetings during the conference.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.54%
Tags
conferences
Rhea-AI Summary
LifeMD, Inc. (LFMD) will participate in the Maxim Group 2024 Healthcare IT Virtual Conference on January 24-25, 2024. The company's management will engage in a virtual fireside chat and one-on-one meetings, offering investors an opportunity to engage with the company.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.01%
Tags
conferences
-
News
Rhea-AI Summary
LifeMD, Inc. (LFMD) expects revenue between $195 and $205 million, a 31% to 38% increase over 2023 guidance. Adjusted EBITDA is expected to be between $18 and $22 million, a 71% to 110% increase over the midpoint of 2023 guidance. The company also anticipates positive full-year free cash flow with estimated year-end 2023 cash exceeding $30 million.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
6.97%
Tags
none
-
Rhea-AI Summary
LifeMD, Inc. (Nasdaq: LFMD) authorizes a cash dividend of $0.5546875 per share for its 8.875% Series A Cumulative Perpetual Preferred Stock (Nasdaq: LFMDP), payable on January 15, 2024, to holders of record on January 5, 2024.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.47%
Tags
dividends
Rhea-AI Summary
LifeMD, Inc.TM (Nasdaq: LFMD) announced a strategic alliance with Medifast (NYSE: MED) to integrate LifeMD’s telehealth platform and GLP-1 offering for medically qualified patients with OPTAVIA Coach-guided, healthy lifestyle solution. Medifast has invested $20 million, including a $10 million payment in support of the collaboration and a $10 million purchase of LifeMD common stock.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-6.42%
Tags
partnership
-
Rhea-AI Summary
Medifast (MED) expands into the medically supported weight loss market through a collaboration with LifeMD (LFMD), making a $20 million capital commitment to drive growth. The company will discontinue its quarterly cash dividend to invest in customer acquisition and experience, aiming to reignite growth in the health and wellness landscape. The collaboration is expected to address the escalating obesity crisis and tap into the $100 billion weight loss market by 2030.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-6.42%
Tags
none
-
Rhea-AI Summary
LifeMD, Inc. (LFMD) to Participate in RWJBarnabas Health Telehealth Symposium, Showcasing the Role of Telehealth in Quality Patient Care
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.89%
Tags
conferences
Rhea-AI Summary
LifeMD, Inc. (LFMD) to participate in upcoming investor conferences and panel discussions. CEO Justin Schreiber to discuss GLP-1s at Cantor Fitzgerald panel and digital health at BTIG forum. Sidoti's Small-Cap Virtual Conference to feature corporate overview and one-on-one investor meetings.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.03%
Tags
conferences

FAQ

What is the current stock price of LifeMD (LFMD)?

The current stock price of LifeMD (LFMD) is $5.04 as of December 20, 2024.

What is the market cap of LifeMD (LFMD)?

The market cap of LifeMD (LFMD) is approximately 217.4M.

What services does LifeMD offer?

LifeMD offers virtual primary care, telemedicine, laboratory and pharmacy services, and specialized treatment for over 200 conditions.

What are the main revenue segments for LifeMD?

LifeMD operates through two segments: Telehealth and WorkSimpli, with the majority of its revenue generated from the Telehealth segment.

How does LifeMD ensure the security of patient interactions?

LifeMD uses a HIPAA-compliant platform with AES-encrypted interactions to ensure the security of communication between patients and healthcare providers.

What is the GLP-1 weight management program?

The GLP-1 weight management program is a medically supported weight loss service that has quickly become a leading provider in the nation, with over 22,000 subscribers as of 2023.

Who are LifeMD's strategic partners?

LifeMD has a strategic alliance with Medifast, which includes a $10 million collaboration fee and a $10 million equity investment.

How does LifeMD plan to grow in 2024?

LifeMD plans to expand its private insurance-based programs, launch new telehealth products under RexMD, and leverage its strategic partnership with Medifast to drive growth.

What is the financial outlook for LifeMD in 2024?

LifeMD expects a revenue growth rate above 30%, significant improvements in adjusted EBITDA, and GAAP earnings for 2024.

What types of telehealth equipment does LifeMD provide?

LifeMD provides custom-fabricated mobile diagnostic telehealth equipment such as cases, carts, and kiosks.

Is LifeMD's service available 24/7?

Yes, LifeMD's telehealth services are available 24/7/365, ensuring round-the-clock healthcare access for patients.

How does LifeMD integrate its telehealth services?

LifeMD's platform integrates electronic medical records, proprietary algorithms, customer relationship management, remote lab testing, digital prescriptions, and cloud pharmacy fulfillment.

LifeMD, Inc.

Nasdaq:LFMD

LFMD Rankings

LFMD Stock Data

217.41M
35.87M
15.71%
40.52%
13.55%
Health Information Services
Services-offices & Clinics of Doctors of Medicine
Link
United States of America
NEW YORK